New cell therapy tested for tough blood cancers
NCT ID NCT05336409
Summary
This early-stage study tested a new cell therapy called CNTY-101 in 28 patients with relapsed or hard-to-treat B-cell blood cancers. The main goals were to find a safe dose and see how the body processes the treatment. The study was terminated early, and it focused on patients who had already tried several other treatments without success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Corewell Health
Grand Rapids, Michigan, 49503, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Houston Methodist Research Institute
Houston, Texas, 77030, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Oncology Hematology Care, Inc-Kenwood
Cincinnati, Ohio, 45236, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
UT Southwestern
Dallas, Texas, 75390, United States
-
University of California San Diego, Moores Cancer Center
San Diego, California, 92093, United States
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45229, United States
-
University of Kentucky - Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
-
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.